|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0042900,
umls-concept:C0065767,
umls-concept:C0087111,
umls-concept:C0439611,
umls-concept:C0596545,
umls-concept:C0853073,
umls-concept:C1553423,
umls-concept:C1704892,
umls-concept:C2603343,
umls-concept:C2825951
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-3-22
|
|
pubmed:abstractText |
PUVA therapy remains a primary treatment for vitiligo, despite unsatisfactory results. Because of calcipotriol's reported effects on melanocytes and on immunomodulatory and inflammatory mediators we wondered whether adding calcipotriol to PUVA would be more effective than PUVA alone in treating vitiligo.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0190-9622
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
634-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11260538-Adult,
pubmed-meshheading:11260538-Aged,
pubmed-meshheading:11260538-Calcitriol,
pubmed-meshheading:11260538-Chemotherapy, Adjuvant,
pubmed-meshheading:11260538-Dermatologic Agents,
pubmed-meshheading:11260538-Female,
pubmed-meshheading:11260538-Humans,
pubmed-meshheading:11260538-Male,
pubmed-meshheading:11260538-Middle Aged,
pubmed-meshheading:11260538-PUVA Therapy,
pubmed-meshheading:11260538-Prospective Studies,
pubmed-meshheading:11260538-Treatment Failure,
pubmed-meshheading:11260538-Vitiligo
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study.
|
|
pubmed:affiliation |
Department of Dermatology, Hacettepe University School of Medicine, Ankara, Turkey.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
